PortalPublikationenCo-morbidity and age-related prevalence of psoriasis: Analys...

Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.

Standard

Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. / Augustin, Matthias; Reich, Kristian; Glaeske, Gerd; Schäfer, Ines; Radtke, Marc.

in: ACTA DERM-VENEREOL, Jahrgang 90, Nr. 2, 2, 2010, S. 147-151.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Augustin, M, Reich, K, Glaeske, G, Schäfer, I & Radtke, M 2010, 'Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.', ACTA DERM-VENEREOL, Jg. 90, Nr. 2, 2, S. 147-151. https://doi.org/10.2340/00015555-0770

APA

Augustin, M., Reich, K., Glaeske, G., Schäfer, I., & Radtke, M. (2010). Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. ACTA DERM-VENEREOL, 90(2), 147-151. [2]. https://doi.org/10.2340/00015555-0770

Vancouver

Augustin M, Reich K, Glaeske G, Schäfer I, Radtke M. Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany. ACTA DERM-VENEREOL. 2010;90(2):147-151. 2. https://doi.org/10.2340/00015555-0770

Bibtex

@article{9d39f9f809ba49319b8cc157059304d4,
title = "Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.",
abstract = "Epidemiological studies indicate an increased risk of co-morbidities and an association with other inflammatory diseases in psoriasis. However, most analyses have been performed on small samples of patients. The aim of this study was to evaluate the prevalence of co-morbidities in psoriasis based on a large set of health insurance data. The database of 1.3 million patients in a German nationwide statutory health insurance scheme was analysed. Data-sets of patients with confirmed psoriasis were extracted and analysed for co-morbidities. Of 1,344,071 subjects, 33,981 had a diagnosis of psoriasis (prevalence 2.5%). Metabolic syndrome was 2.9-fold more frequent among these patients. The most common diagnoses were arterial hypertension (35.6% in psoriasis vs. 20.6% in controls) and hyperlipidaemia (29.9% vs. 17.1%). The frequencies of rheumatoid arthritis (prevalence ratio (PR) 3.8), Crohn's disease (PR 2.1) and ulcerative colitis (PR 2.0) were also increased among patients with psoriasis. In conclusion, psoriasis is associated with significant co-morbidities that imply an elevated risk of severe complications.",
author = "Matthias Augustin and Kristian Reich and Gerd Glaeske and Ines Sch{\"a}fer and Marc Radtke",
year = "2010",
doi = "10.2340/00015555-0770",
language = "Deutsch",
volume = "90",
pages = "147--151",
journal = "ACTA DERM-VENEREOL",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato-Venereologica",
number = "2",

}

RIS

TY - JOUR

T1 - Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany.

AU - Augustin, Matthias

AU - Reich, Kristian

AU - Glaeske, Gerd

AU - Schäfer, Ines

AU - Radtke, Marc

PY - 2010

Y1 - 2010

N2 - Epidemiological studies indicate an increased risk of co-morbidities and an association with other inflammatory diseases in psoriasis. However, most analyses have been performed on small samples of patients. The aim of this study was to evaluate the prevalence of co-morbidities in psoriasis based on a large set of health insurance data. The database of 1.3 million patients in a German nationwide statutory health insurance scheme was analysed. Data-sets of patients with confirmed psoriasis were extracted and analysed for co-morbidities. Of 1,344,071 subjects, 33,981 had a diagnosis of psoriasis (prevalence 2.5%). Metabolic syndrome was 2.9-fold more frequent among these patients. The most common diagnoses were arterial hypertension (35.6% in psoriasis vs. 20.6% in controls) and hyperlipidaemia (29.9% vs. 17.1%). The frequencies of rheumatoid arthritis (prevalence ratio (PR) 3.8), Crohn's disease (PR 2.1) and ulcerative colitis (PR 2.0) were also increased among patients with psoriasis. In conclusion, psoriasis is associated with significant co-morbidities that imply an elevated risk of severe complications.

AB - Epidemiological studies indicate an increased risk of co-morbidities and an association with other inflammatory diseases in psoriasis. However, most analyses have been performed on small samples of patients. The aim of this study was to evaluate the prevalence of co-morbidities in psoriasis based on a large set of health insurance data. The database of 1.3 million patients in a German nationwide statutory health insurance scheme was analysed. Data-sets of patients with confirmed psoriasis were extracted and analysed for co-morbidities. Of 1,344,071 subjects, 33,981 had a diagnosis of psoriasis (prevalence 2.5%). Metabolic syndrome was 2.9-fold more frequent among these patients. The most common diagnoses were arterial hypertension (35.6% in psoriasis vs. 20.6% in controls) and hyperlipidaemia (29.9% vs. 17.1%). The frequencies of rheumatoid arthritis (prevalence ratio (PR) 3.8), Crohn's disease (PR 2.1) and ulcerative colitis (PR 2.0) were also increased among patients with psoriasis. In conclusion, psoriasis is associated with significant co-morbidities that imply an elevated risk of severe complications.

U2 - 10.2340/00015555-0770

DO - 10.2340/00015555-0770

M3 - SCORING: Zeitschriftenaufsatz

VL - 90

SP - 147

EP - 151

JO - ACTA DERM-VENEREOL

JF - ACTA DERM-VENEREOL

SN - 0001-5555

IS - 2

M1 - 2

ER -